Shanghai Fochon Pharmaceutical Co., Ltd.

Chongqing Fochon Pharmaceutical Co., Ltd.

Fochon Pharmaceuticals, Ltd.

Fochon Biosciences, Ltd.

Chinese Academy of Sciences

Qihong Liu

Weibo Wang

Xingdong Zhao

Haohan Tan

Xianlong Wang

Jing Sun

Tongshuang Li

Zuwen Zhou

Yanxin Liu

Lihua Jiang

Rui Tan

Zhifang Chen

Ling Chen

Zhifu Li

Lijun Yang

Li Linghu

Weipeng Zhang

Hongbin Liu

Yue Rong

Qiang Tian

Min Lin

Huajie Zhang

Bin Liu

Chengxi He

Fanxin Zeng

Hailong Shi

Bo Fang

Jian Ding

Meiyu Geng

Shu Lin

Chuiliang Yu

Quan Yuan

Yuwei Gao

Linghua Meng

Zongyao Zou

Yunling Wang

Hong Fu

Provided are certain TRK inhibitors, pharmaceutical compositions thereof, and methods of use thereof.

Macrocyclic compounds as TRK kinases inhibitors

Provided are certain TRK inhibitors of formula (I): pharmaceutical compositions thereof, and methods of use thereof.

Substituted 2-azabicyclo[3.1.0]hexanes as TRK kinases inhibitors

Provided are certain IDO inhibitors or pharmaceutically acceptable salts thereof which can inhibit enzymatic activity of indoleamine 2,3-dioxygenase (IDO) and may be useful for the treatment of diseases and disorders mediated by IDO. In addition, pharmaceutical compositions thereof and methods of use thereof are also provided.

Sulfoximine, sulfonimidamide, sulfondiimine and diimidosulfonamide compounds as inhibitors of indoleamine 2,3-dioxygenase

Provided are certain URAT1 inhibitors, pharmaceutical compositions thereof, and methods of use therefor.

Indolizine derivatives, composition and methods of use

Provided are certain CDK4/6 inhibitors with the structure of formula (I), pharmaceutical compositions thereof, and methods of use therefor. The compounds are of the class of pyrimidin-2 amine derivatives, useful for the treatment of hyper-proliferative diseases. 

Certain protein kinase inhibitor

Provided are certain PI3K inhibitors, pharmaceutical compositions thereof, and methods of use therefor.

Certain protein kinase inhibitors

Provided are compound of formula (I) as certain CDK4/6 inhibitors, pharmaceutical compositions thereof, and methods of use thereof. 

Disclosed herein are protein kinase inhibitors, more particularly pyridazine derivatives and pharmaceutical compositions thereof, and method of use thereof.

Growing community of inventors

Chongqing, China

Qihong Liu